SAFFRON-PHARMA®
Crocus sativus — Moldovan genetic line.
Apocarotenoid pigments — crocins, picrocrocin, safranal — with documented pharmacological interest in neurological and mood-related research. ISO 3632-compatible analytical profiling under standardisation.
Saffron contains specific apocarotenoid pigments and aroma compounds — crocins, picrocrocin, safranal — with documented pharmacological interest in neurological and mood-related research. Pharmaceutical-grade saffron requires verifiable origin, standardised processing, and ISO 3632-compatible analytical profiling. SAFFRON-PHARMA® is the TEHNOFARM® programme operating the Moldovan genetic line of Crocus sativus.
Cultivation status
Moldovan genetic line under NORD NUC operational management. Standardisation of post-harvest drying, stigma separation, and analytical profile is in progress. Public-facing material on saffron.md. Cultivation area, harvest cycle, and processing capacity are confirmed to qualifying partners on request.
Sister programme
The Italian-origin counterpart line operates under ZAFFERANO-PHARMA® — same species, distinct origin claim, distinct supply chain. The two programmes together form one R&D framework with two genetic-and-geographic origin offerings.
Engagement
Pharmaceutical extractors, neuroscientific research procurement, and premium nutraceutical buyers: contact@tehnofarm.md. Subject line: SAFFRON-PHARMA® inquiry.